A breakthrough drug that saves the lives of mice with a rare, fatal disease is moving toward human trials thanks to a $10 million donation from a family who lost a loved one to the condition.
The therapy works by teaching the body's cells to destroy the malformed proteins that kill patients with RVCL.
Want to know more?